Piriformis Syndrome Treatment Market: Overview
Piriformis syndrome is a neuromuscular disorder, wherein the piriformis muscles squeeze the sciatic nerves, causing spasms and buttock pain. Piriformis is a small muscle located behind the gluteus maximus, deep in the buttock. This syndrome also causes pain, numbness, and tingling in the foot and back of legs. Piriformis muscles are important for lower body movement, as these enable maintaining body balance, walking, and even shifting of weight from one foot to other. These muscles are used in motion of hips and legs, and majorly in sports which involve movement of the thighs. The cause of piriformis syndrome is unknown; however, some estimated causes are irritation in the piriformis muscles or in the sacroiliac joint or hip, tightening or swelling of the muscles in response to or due to injury or spasm or in some cases bleeding in the piriformis muscle area.
Piriformis Syndrome Treatment Market: Key Trends
Increase in incidence of piriformis syndrome and proper screening & diagnosis of the syndrome are the major factors driving the global piriformis syndrome treatment market. Launch of innovative drugs, rise in awareness about diagnosis of the syndrome, and increase in geriatric population are projected to propel the global market. Investments by key players in spreading awareness about the prevalence of piriformis syndrome and its treatments is anticipated to contribute to the growth of the global piriformis syndrome treatment market. However, there are certain challenges in the diagnosis of the syndrome, especially in the developing counties. This is expected to hamper market growth. Moreover, complications during surgeries and lack of awareness in developing countries are the other factors likely to restrain the piriformis syndrome treatment market. A research published on Medscape in December 2018 stated that the incidence ratio of piriformis syndrome is 6 women to 1 man in the U.S. Moreover, the incidence of piriformis syndrome in patients with sciatica is 6% in the country. A study conducted at a local hospital in the U.S. revealed that of the 750 patients with lower back problem (LBP), 45 were suffering from piriformis syndrome. According to study update on NCBI, the estimated new cases of back pain and sciatica is 40 million per year, and incidence rate of piriformis syndrome is around 2.4 million per year.
Piriformis Syndrome Treatment Market: Segmentation
The global piriformis syndrome treatment market can be segmented based on treatment, end-user, and region. In terms of treatment, the piriformis syndrome treatment market can be classified into medication, physical therapy, osteopathic manipulative treatment (OMT), prolotherapy, surgery, and others. Based on end-user, the global piriformis syndrome treatment market can be divided into hospitals, clinics, ambulatory surgical centers, and others.
Piriformis Syndrome Treatment Market: Regional Analysis
In terms of region, the global piriformis syndrome treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2018, and the trend is projected to continue during the forecast period. This is due to increase in incidence of piriformis syndrome, rise in awareness about the causes of piriformis syndrome, surge in health care expenditure, and diagnosis of the syndrome. Moreover, advanced health care facilities, awareness about the required surgeries, favorable reimbursement policies, and new products in the market are anticipated to boost the growth of the piriformis syndrome treatment market in the region. Europe held the second largest share of the global market in 2018. Rise in prevalence of piriformis syndrome and government support for research & development are expected to drive the piriformis syndrome treatment market in the region. Increase in the geriatric population and rise in awareness about piriformis syndrome and its treatment are the factors fueling the growth of the market in the region. People in other regions are unaware of the diagnosis of piriformis syndrome. This is likely to change due to improving infrastructure and availability of diagnostic tools in the developing regions.
Piriformis Syndrome Treatment Market: Competitive Landscape
Major players operating in the global piriformis syndrome treatment market include Bayer AG, Novartis AG, AstraZeneca, Endo Pharmaceuticals, Inc., Teva Pharmaceuticals Industries Ltd., Omron Healthcare, Sanofi, Miracle Stretch, LLC, Nidd Valley Medical, and SEIRIN Corporation.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.